IGFBP6 and type 1 diabetes mellitus: A number of studies have investigated circulating IGFBP6 levels in various neoplastic and non-malignant disorders, including renal, neurologic and ocular diseases, and type 1 diabetes (T1D) in order to evaluate its clinical relevance.